ciprofloxacin has been researched along with Infectious Diseases in 10 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ciprofloxacin is a broad spectrum fluoroquinolone antibacterial agent." | 2.39 | Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability. ( Balfour, JA; Davis, R; Markham, A, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Turaihi, TSA | 1 |
| Mubark, HA | 1 |
| Hadi, ZJ | 1 |
| Akool, MA | 1 |
| Al-Nafak, RT | 1 |
| Yedle, R | 1 |
| Reniguntla, MK | 1 |
| Puttaswamy, R | 1 |
| Puttarangappa, P | 1 |
| Hiremath, S | 1 |
| Nanjundappa, M | 1 |
| Jayaraman, R | 1 |
| Edson, RS | 1 |
| Litin, SC | 1 |
| Bundrick, JB | 1 |
| Lorenzana, N | 1 |
| Avila, LF | 1 |
| Alonso, S | 1 |
| Colado, E | 1 |
| Bernal, T | 1 |
| Welling, M | 1 |
| Stokkel, M | 1 |
| Balter, J | 1 |
| Sarda-Mantel, L | 1 |
| Meulemans, A | 1 |
| Le Guludec, D | 1 |
| Davis, R | 1 |
| Markham, A | 1 |
| Balfour, JA | 1 |
| Ivanov, RN | 1 |
| Salazar, R | 1 |
| Solá, C | 1 |
| Maroto, P | 1 |
| Tabernero, JM | 1 |
| Brunet, J | 1 |
| Verger, G | 1 |
| Valentí, V | 1 |
| Cancelas, JA | 1 |
| Ojeda, B | 1 |
| Mendoza, L | 1 |
| Rodríguez, M | 1 |
| Montesinos, J | 1 |
| López-López, JJ | 1 |
| Engels, EA | 1 |
| Ellis, CA | 1 |
| Supran, SE | 1 |
| Schmid, CH | 1 |
| Barza, M | 1 |
| Schenkein, DP | 1 |
| Koc, Y | 1 |
| Miller, KB | 1 |
| Wong, JB | 1 |
| Frisolone, J | 1 |
| Ostrosky, J | 1 |
| Symes, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Drug Utilization Evaluation Study of Ciprofloxacin Utilization and Adverse Events Occurrence in Community Pharmacy Setting: A Cross-Sectional Study[NCT05916105] | 151 participants (Actual) | Observational | 2021-09-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for ciprofloxacin and Infectious Diseases
| Article | Year |
|---|---|
Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.
Topics: Anti-Infective Agents; Ciprofloxacin; Communicable Diseases; Drug Interactions; Drug Tolerance; Econ | 1996 |
9 other studies available for ciprofloxacin and Infectious Diseases
| Article | Year |
|---|---|
ANTIBIOTIC RESISTANCE OF SALMONELLA TYPHI CARRIER ASSOCIATED WITH GALL BLADDER CHRONIC INFECTION IN AL-NAJAF PROVINCE.
Topics: Ampicillin; Anti-Bacterial Agents; Cefepime; Cefixime; Chloramphenicol; Ciprofloxacin; Communicable | 2023 |
Neutropenic Rat Thigh Infection Model for Evaluation of the Pharmacokinetics/Pharmacodynamics of Anti-Infectives.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Communicable Disease | 2023 |
Clinical Pearls in Infectious Diseases 2017.
Topics: Administration, Intravaginal; Adult; Aged; Anti-Bacterial Agents; Body Piercing; Campylobacter Infec | 2017 |
The impact of antimicrobial prophylaxis in morbidity and infections during azacitidine treatment.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Antimetabolites, Antineo | 2017 |
The many roads to infection imaging.
Topics: Ciprofloxacin; Communicable Diseases; Diagnostic Imaging; Humans; Molecular Probe Techniques; Sensit | 2008 |
[The use of Ciprobay in the infectious complications of traumatic illness].
Topics: Anti-Infective Agents; Ciprofloxacin; Communicable Diseases; Humans; Wounds and Injuries | 1997 |
Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
Topics: Acyclovir; Adolescent; Adult; Anti-Infective Agents; Antifungal Agents; Antineoplastic Combined Chem | 1999 |
Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk.
Topics: Adult; Anti-Bacterial Agents; Bone Marrow Transplantation; Ciprofloxacin; Communicable Diseases; Fem | 1999 |
Criteria for use of ciprofloxacin for infections in adult patients.
Topics: Adult; Ciprofloxacin; Communicable Diseases; Drug Evaluation; Humans; Information Services; Middle A | 1990 |